Essential roles for NF-κB and a Toll/IL-1 receptor domain-specific signal(s) in the induction of IκB-ζ

Biochemical and Biophysical Research Communications

Volumn 301, Issue 2, 2003, Pages 495-501

  Eto, Akiko ^a   Muta, Tatsushi ^a,b   Yamazaki, Soh ^a   Takeshige, Koichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Innate immunity; I B ; Macrophage; Nuclear factor B; Toll like receptor; Toll interleukin 1 receptor domain; Transcriptional induction

Indexed keywords

I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B ZETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA; PROTEIN DERIVATIVE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0037423696     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)03082-6     Document Type: Article

References (33)

1. Medzhitov R., Janeway C.A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
2. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787.
3. Takeuchi O., Akira S. Genetic approaches to the study of Toll-like receptor function. Microbes Infect. 4:2002;887-895.
4. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
5. Baker B., Zambryski P., Staskawicz B., Dinesh-Kumar S.P. Signaling in plant-microbe interactions. Science. 276:1997;726-733.
6. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A. The human Toll signaling pathway: divergence of nuclear factor. κ B and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) J. Exp. Med. 187:1998;2097-2101.
7. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2:1998;253-258.
8. Irie T., Muta T., Takeshige K. TAK1 mediates an activation signal from Toll-like receptor(s) to nuclear factor-. κ B in lipopolysaccharide-stimulated macrophages FEBS Lett. 467:2000;160-164.
9. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-. κB activity Annu. Rev. Immunol. 18:2000;621-663.
10. Pahl H.L. Activators and target genes of Rel/NF-. κB transcription factors Oncogene. 18:1999;6853-6866.
11. Yamazaki S., Muta T., Takeshige K. A novel. IκB protein, Iκ B- ζ, induced by proinflammatory stimuli, negatively regulates nuclear factor- κ B in the nuclei J. Biol. Chem. 276:2001;27657-27662.
12. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-. κB induction by TNF, CD95 and IL-1 Nature. 385:1997;540-544.
13. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IκB kinase- β: NF- κB activation and complex formation with IκB kinase- α and NIK Science. 278:1997;866-869.
14. Muta T., Takeshige K. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of Toll-like receptor (TLR)2 as well as TLR4. Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur. J. Biochem. 268:2001;4580-4589.
15. Perkins N.D. The Rel/NF-. κB family: friend and foe Trends Biochem. Sci. 25:2000;434-440.
16. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., Sims J.E., Bird T.A., O'Neill L.A.J. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
17. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:2001;835-841.
18. Chung J.Y., Park Y.C., Ye H., Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115:2002;679-688.
19. Shinkura R., Kitada K., Matsuda F., Tashiro K., Ikuta K., Suzuki M., Kogishi K., Serikawa T., Honjo T. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-. κ B-inducing kinase Nat. Genet. 22:1999;74-77.
20. Yin L., Wu L., Wesche H., Arthur C.D., White J.M., Goeddel D.V., Schreiber R.D. Defective lymphotoxin-. β receptor-induced NF- κB transcriptional activity in NIK-deficient mice Science. 291:2001;2162-2165.
21. Matsushima A., Kaisho T., Rennert P.D., Nakano H., Kurosawa K., Uchida D., Takeda K., Akira S., Matsumoto M. Essential role of nuclear factor (NF)-. κ B-inducing kinase and inhibitor of κ B ( IκB ) kinase α in NF- κB activation through lymphotoxin β receptor, but not through tumor necrosis factor receptor I J. Exp. Med. 193:2001;631-636.
22. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
23. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
24. Kataoka K., Muta T., Yamazaki S., Takeshige K. Activation of macrophages by linear (. 1→3 )- β -D-Glucans. Implications for the recognition of fungi by innate immunity J. Biol. Chem. 277:2002;36825-36831.
25. Schreck R., Meier B., Männel D.N., Dröge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor. κ B activation in intact cells J. Exp. Med. 175:1992;1181-1194.
26. 2 in NF- κB activation by either cytokine in both primary and transformed endothelial cells J. Biol. Chem. 272:1997;25941-25950.
27. Yin M.-J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of. IκB kinase- β Nature. 396:1998;77-80.
28. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8:1998;397-403.
29. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
30. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-. κB by Toll-like receptor 3 Nature. 413:2001;732-738.
31. Israël A. The IKK complex: an integrator of all signals that activate NF-. κB ? Trends Cell Biol. 10:2000;129-133.
32. Schmitz M.L., Bacher S., Kracht M. IκB -independent control of NF- κB activity by modulatory phosphorylations Trends Biochem. Sci. 26:2001;186-190.
33. Ghosh S., Karin M. Missing pieces in the NF-. κB puzzle Cell. 109:2002;S81-S96.